Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02755324Completed
Open-label, single-arm trial, sponsored by Leiden University. Primary endpoints: Number of grade 3 and 4 adverse events, possibly, probably or definitely related to controlled human Schistosoma mansoni infection with male cercariae at 20 weeks and The number of male cercariae at which 100% volunteers show detectable Schistosoma mansoni circulating anodic antigen (CAA) at 12 weeks. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02755324.